2 weeks 3 days ago
Social determinants of health (SDH) impact diabetes outcomes. In response to COVID-19, virtual care ensured healthcare access. However, socially disadvantaged groups have less technology access and skills, leading to potential disparities. We assessed the association between SDH and virtual visit success in children living with diabetes.
Laurence Bastien, Ellen B. Goldboom, Ewa Sucha, Richard J. Webster, Ivan Terekhov, Caroline Zuijdwijk
2 weeks 3 days ago
Published data still highlighted discordances between GMI (parameter estimating HbA1c from CGM report) and laboratory HbA1c, with reasons yet to be explored. This study aimed: to identify potential clinical factors contributing to these discordances.
Grażyna Deja, Aleksandra Brudzińska, Łukasz Wybrańczyk, Rafal Deja, Przemysława Jarosz-Chobot.
3 weeks 4 days ago
Diabetes and prediabetes are associated with premature death and are recognized as conditions of accelerated biologic aging. To date, the best measurement of biologic age is chronologic age. Measures of biologic age that can replace chronologic age as a predictor of death can better approximate risk in affected individuals.
Hertzel C. Gerstein, Guillaume Pare, Keyun Zhou, Serena Yang, Michael Chong, Gregory R. Steinberg, Shun Fu Lee
1 month ago
The rising incidence of type 2 diabetes (T2D) among Indigenous peoples, exacerbated by historical injustices and health inequities, underscores the need for culturally-sensitive health interventions that address both the physiological and psychological burdens of diabetes. This research protocol describes a community-driven initiative aimed at enhancing diabetes management among Indigenous youth and young adults in Canada, leveraging the lived experience and leadership of Indigenous young adults.
Sahar Fazeli, Jonathan Linton, Paul Linton, Lucy Trapper, Catherine Godin, Helene Porada, Deborah Da Costa, Kaberi Dasgupta, Isabelle Malhame, Claudia Mitchell, Elham Rahme, Julia Elisabeth Von Oettingen, Romina Pace
1 month ago
Trials using intensive lifestyle interventions have demonstrated remission of type 2 diabetes mellitus (T2DM), but data on real-world clinical approaches remain limited.
Christopher Gudas-Cantin, Valérie Dionne, Élise Latour, Karine Lamoureux, Lyne Chevrefils, Chantal Gariepy, Marie-Hélène Morissette C, Lina Mokdad, Juliette Morin, Sarah-Maude Martin, Mathieu Gayda, Florent Besnier, Sara Desmarais, Anil Nigam, Philippe L…
1 month ago
Kara Hawker, Justin Morein, Gurleen Gill, Irena Druce
1 month 1 week ago
Glucagon-like peptide 1 receptor agonists (GLP1RA), a relatively new class of drugs, are widely used in treating type 2 diabetes mellitus and obesity. Maintaining long-term glycemic control lowers the risk of development and progression of diabetic retinopathy. However, recent literature has raised concerns about transient worsening of the condition with GLP1RA use.
Nadia Nadeem, Raghad Mazin Al Issa, Asnin Shah, Rahaf Wardeh, Fauzia Rashid, Elamin Ibrahim Abdelgadir, Alaaeldin Bashier
1 month 1 week ago
Noor un nisa, Syeda Sana-e-Zehra Naqvi
1 month 2 weeks ago
Obesity and aging are associated with increased activity of the innate immune system. This chronic systemic inflammation contributes to the development of type 2 diabetes and long-term complications and is partly driven by the activation of the NLRP3 inflammasome. We conducted a comparative analysis of clinical parameters, non-esterified fatty acid (NEFA) profiles, immune cell subsets, and inflammatory responses of peripheral blood mononuclear cells obtained from both healthy individuals and those diagnosed with type 2 diabetes.
Joyce de Paula Souza, Justus S. Fischer, Karine Jeanneau, Cyril Allard, Eline Angevaare, Dominik Aschenbrenner, Ursula Bodendorf, Benjamin Demarco, John S. Gounarides, Saskia Killmer, Jiri Kovarik, Sabina Pfister, Hong Yin, Vithushan Ratnarasa, Marianne…
1 month 3 weeks ago
Patient-centered care is a hallmark of family medicine, and patient-centered care for diabetes has been associated with better outcomes. The Primary Care Diabetes Support Program (PCDSP) in London, Ontario, uses a patient-centered model of care and targets three groups of patients at high risk for diabetes complications: 1) medically complex, 2) socially complex, and 3) those without a primary care provider. We describe, from the patient’s perspectives, how the PCDSP operationalizes patient-centered care.
Gillian Young, Anika Garg, Dana Ryan, Leslie Meredith, Stewart Harris, Sonja M. Reichert, Lindsay Hedden, Maria Mathews
1 month 4 weeks ago
Muhammad Tabish, Hamna Khan, Muhammad Naveed
2 months ago
Krishna Jaipal, Sanjana Bebu Punshi, Mehak Kumari Bansari
2 months ago
Masashi Hasebe, Chen-Yang Su
2 months 2 weeks ago
Shorrem Naeem, Zainab Arif
2 months 2 weeks ago
Ontario listed SGLT-2 inhibitors (SGLT2i) as regular public drug benefits for adults age ≥ 65, while other Canadian provinces providing benefits for SGLT2i implemented special authorization restrictions. We hypothesized that special authorization led to lower SGLT2i use among older adults with diabetes and cardiovascular disease (CVD) in other provinces (Alberta, Manitoba, New Brunswick, and Saskatchewan), compared to Ontario.
Darren Lau, Douglas C. Dover, Hena Qureshi, Roseanne O. Yeung, Dean Eurich, Peter Senior, Sonia Butalia, Padma Kaul
2 months 2 weeks ago
To assess the feasibility and acceptability of a patient navigator (PN) in a pediatric type 1 diabetes (T1D) clinic.
Elise Schlissel Tremblay, Ashley B. Tartarilla, Kali McCollister, Mia Umali, Melicia Y. Whitley, Julia Ainsworth, Patrice Melvin, Lori M. Laffel, Valerie L. Ward
2 months 2 weeks ago
Adolescents and young adults (AYA) often report feeling poorly prepared and dissatisfied with the process of transitioning from pediatric to adult type 1 diabetes (T1D) care. We aimed to examine the impact of Bridging the Gap (BTG), an audit and feedback-based intervention, on transition care.
Syed Zain Ahmad, Noah Ivers, Ian Zenlea, Baiju R. Shah, Peter C. Austin, Cheril Clarson, Jennifer Harrington, Alanna Landry, Geetha Mukerji, Zubin Punthakee, Mark R. Palmert, Janet Parsons, Mikayla Sonnenberg, Rayzel Shulman
2 months 3 weeks ago
We appreciate the interest of Huda and colleagues with regard to our recent article examining the national trends in lower extremity complications related to type 1 and type 2 diabetes mellitus [1,2]. We agree that a more comprehensive understanding of the temporal trends in diabetes-related foot complications and limb amputation is limited by several factors, mostly pertaining to data availability at a pan-Canadian level. There are no Canadian Institute for Health Information data holdings that allow one to identify a diabetes diagnosis date across the Canadian population; this contrasts with validated province-based databases, such as the Ontario Diabetes Database [3].
Angela Y. Kim, James Hanley, Rebecca Fuhrer, Charles de Mestral
2 months 3 weeks ago
Syed Aaraiz Ul Hassan, Krishna Jaipal Lohana, Shorrem Naeem
2 months 3 weeks ago
Our aim in this study was to compare severe hypoglycemia and all-cause mortality between insulin regimens in people with type 2 diabetes on insulin.
Reid H. Whitlock, Zach Raizman, David Collister, Katherine J. Bernier, Sarah M. Sigurdson, Navdeep Tangri, Clara Bohm, Claudio Rigatto, Paul Komenda, Jennifer M. Yamamoto
Checked
24 minutes 23 seconds ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
